COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,722 Articles (22,502 medRxiv, 8,220 bioRxiv)

Most recent first Previous |  Page 1367: Articles 13661-13670  | Next

Strong immunogenicity of heterologous prime-boost immunizations with the experimental vaccine GRAd-COV2 and BNT162b2 or ChAdOx1-nCOV19
Agrati, C., Capone, S., Castilletti, C., Cimini, E., Matusali, G., Meschi, S., Tartaglia, E., Camerini, R., Lanini, S., Milleri, S., Colloca, S., Vitelli, A., Folgori, A.
10.1101/2021.06.22.21258961 — Posted: 2021-06-28
Models of COVID-19 vaccine prioritisation: a systematic literature search and narrative review
Saadi, N., Chi, Y.-L., Ghosh, S., Eggo, R. M., McCarthy, C., Quaife, M., Dawa, J., Jit, M., Vassall, A.
10.1101/2021.06.21.21259104 — Posted: 2021-06-28
Effectiveness of vaccination against SARS-CoV-2 infection and Covid-19 hospitalization among Finnish elderly and chronically ill - An interim analysis of a nationwide cohort study
Baum, U., Poukka, E. J., Palmu, A., Salo, H., Lehtonen, T. O., Leino, T.
10.1101/2021.06.21.21258686 — Posted: 2021-06-28 Discussion: Onsite
Long Term Health Consequences of COVID-19 in Hospitalized Patients from North India: A follow up study of upto 12 months
Budhiraja, S., Aggarwal, m., Wig, R., Tyagi, A., Mishra, R. S., Mahajan, M., Kirtani, J., Tickoo, R. R., Dewan, A., Aggarwal, R., Saxena, P., Singh, N., Kumar, A., Chugh, I. M., Aneja, P., Dhall, S., Boobna, V., Arora, V., Jha, S., Indrayan, A., bali, s.
10.1101/2021.06.21.21258543 — Posted: 2021-06-28
Is Second dose of vaccination useful in previously SARS-CoV-2 infected Health Care Workers?
Pean de Ponfilly, G., Pilmis, B., El Kaibi, I., Castreau, N., Laplanche, S., Le Monnier, A.
10.1101/2021.06.22.21257103 — Posted: 2021-06-28
Changes in mobility pre and post first SARS-CoV-2 vaccination: findings from a prospective community cohort study including GPS movement tracking in England and Wales (Virus Watch)
Nguyen, V., Liu, Y., Mumford, R., Flanagan, B., Patel, P., Braithwaite, I., Shrotri, M., Byrne, T. E., Beale, S., Aryee, A., Fong, W. L. E., Fragaszy, E., Geismar, C., Navaratnam, A. M. D., Hardelid, P., Kovar, J., Pope, A., Cheng, T., Hayward, A., Aldridge, R. W., The Virus watch Collaborative
10.1101/2021.06.21.21259237 — Posted: 2021-06-28
Meta-analytical evidence on mental disorder symptoms during the COVID-19 pandemic in Latin America
Zhang, S. X., Batra, K., Liu, T., Dong, R. K., Xu, W., Yin, A., Delios, A., Chen, B. Z., Chen, R. Z., Miller, S., Wan, X., Chen, J.
10.1101/2021.06.21.21259299 — Posted: 2021-06-28
Detection of B.1.351 and B.1.1.7 SARS-CoV-2 variants in Monterrey metropolitan area in Northeast Mexico
Galan-Huerta, K. A., Garza-de-la-Pena, E., Elizondo-Valdez, G. V., Herrera-Saldivar, M. F., Rivas-Estilla, A. M., Lozano-Sepulveda, S. A., Martinez-Acuna, N., Arellanos-Soto, D., Ramos-Jimenez, J.
10.1101/2021.06.21.21258579 — Posted: 2021-06-28
Rapid protocols to support Covid-19 clinical diagnosis based on hematological parameters
Gomes, J. C., Barbosa, V. A. d. F., de Santana, M. A., de Lima, C. L., Calado, R. B., Bertoldo Junior, C. R., Albuquerque, J. E. d. A., de Souza, R. G., de Araujo, R. J. E., Moreno, G. M. M., Soares, L. A. L., Mattos Junior, L. A. R., de Souza, R. E., dos Santos, W. P.
10.1101/2021.06.21.21259252 — Posted: 2021-06-28
Development and validation of blood-based prognostic biomarkers for severity of COVID disease outcome using EpiSwitch 3D genomic regulatory immuno-genetic profiling.
Hunter, E., Koutsothanasi, C., Wilson, A., Santos, F. C., Salter, M., Westra, J., Powell, R., Dring, A., Brajer, P., Egan, B., Matthew, P., Catriona, W., Aemilia, K., Thomas, L., Ramadass, A., Messner, W., Brunton, A., Lyski, Z., Robbins, P., Mellor, J., Vancheeswaran, R., Barlow, A., Pchejetski, D., Akoulitchev, A.
10.1101/2021.06.21.21259145 — Posted: 2021-06-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).